Cargando…
Effects of a Behavioral Weight Loss Intervention and Metformin Treatment on Serum Urate: Results from a Randomized Clinical Trial
Background: Lower body mass index (BMI) has been associated with lower serum urate (SU), but only in observational studies. We sought to determine the effects of behavioral weight loss and metformin treatment on SU in a randomized trial. Methods and Findings: The Survivorship Promotion In Reducing I...
Autores principales: | Hu, Jiun-Ruey, Yeh, Hsin-Chieh, Mueller, Noel T., Appel, Lawrence J., III, Edgar R. Miller, Maruthur, Nisa M., Jerome, Gerald J., Chang, Alex R., Gelber, Allan C., Juraschek, Stephen P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8401432/ https://www.ncbi.nlm.nih.gov/pubmed/34444833 http://dx.doi.org/10.3390/nu13082673 |
Ejemplares similares
-
A behavioral weight-loss intervention, but not metformin, decreases a marker of gut barrier permeability: Results from the SPIRIT randomized trial
por: Tilves, Curtis, et al.
Publicado: (2022) -
Metformin Affects Gut Microbiome Composition and Function and Circulating Short-Chain Fatty Acids: A Randomized Trial
por: Mueller, Noel T., et al.
Publicado: (2021) -
Increases in Circulating and Fecal Butyrate are Associated With Reduced Blood Pressure and Hypertension: Results From the SPIRIT Trial
por: Tilves, Curtis, et al.
Publicado: (2022) -
Metformin Use in Prediabetes Among U.S. Adults, 2005–2012
por: Tseng, Eva, et al.
Publicado: (2017) -
A Randomized Pilot Study of DASH Patterned Groceries on Serum Urate in Individuals with Gout
por: Juraschek, Stephen P., et al.
Publicado: (2021)